Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant
Clinical trial NCT05899829 · COMPLETED
Trial details
- NCT number
- NCT05899829
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2023-08-08
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.